Tumor-derived exosomal lncRNA SNHG4 promotes triple-negative breast cancer progression by targeting XPO5
BackgroundTriple-negative breast cancer (TNBC) is the subtype of advanced breast cancer with the shortest survival time and the poorest prognosis, and treatment options are relatively limited. Exosomes, small extracellular vesicles enriched with bioactive molecules, are critical mediators of interce...
Saved in:
Main Authors: | Zhi-Wen Wang, Hou-Sheng Yang, Hong-Shan Guo, Yue-Ying Li, Jin-Yun Zhong, Shu Jiang, Jia-Peng Li, Zhong-Yi Yang, Chuan-Yi Zhou, Jun Wang, Xing-Hua Liao, Lei Mao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1593827/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging role of extracellular microRNAs and lncRNAs
by: Geyu Zhou, et al.
Published: (2019-03-01) -
Unraveling LncRNA GAS5 in Atherosclerosis: Mechanistic Insights and Clinical Translation
by: Yu Wei, et al.
Published: (2025-06-01) -
The expression level and clinical significance of lncRNA X91348 in hepatocellular carcinoma
by: Zhen Zeng, et al.
Published: (2019-12-01) -
Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network
by: Rui Li, et al.
Published: (2019-12-01) -
The potential value of lncRNA-BC050642 in osteosarcoma origination and outcomes
by: Yang Yang, et al.
Published: (2019-12-01)